Table 1. Incidence age standardised rates (ASRs) per 100 000 15–90+ year olds, cases, total percentage changes and average annual percentage changes (AAPC) for 1993 (observed), 2014 (observed) and 2035 (projected) by cancer site and sex.

	1993 ASR	2014 ASR	2035 ASR	ASR % change 2014–2035	ASR AAPC 2015–2035	1993 Cases	2014 Cases	2035 Cases	Cases % change 2014–2035	Cases AAPC 2015–2035
Males
Cancer site
Anus	1.73	1.84	2.18	18.24	0.62	284	434	684.68	57.76	2.01
Bladder	61.52	33.92	21.07	−37.88	−2.33	9705	7301	7531.11	3.15	0.16
Bone	0.91	1.01	0.69	−31.35	−1.91	189	256	216.77	−15.33	−0.84
Bowel	105.04	102.38	86.92	−15.10	−0.86	16 929	22 827	29 356.10	28.60	1.13
Brain	17.41	21.08	22.11	4.87	0.14	3364	5036	6884.30	36.70	1.40
Hodgkin lymphoma	3.50	4.48	4.87	8.86	0.52	810	1148	1479.68	28.89	1.27
Kidney	19.12	34.18	43.88	28.38	1.08	3275	7778	14 258.84	83.32	2.75
Larynx	10.91	8.36	6.52	−22.04	−1.19	1902	1920	2099.54	9.35	0.41
Leukaemia	21.22	24.14	25.59	6.00	0.13	3461	5425	8714.08	60.63	2.11
Liver	6.36	16.21	23.23	43.27	1.41	1043	3636	7769.55	113.68	3.28
Lung	167.74	112.25	97.06	−13.54	−0.70	27 112	24 767	32 874.81	32.74	1.34
Malignant melanoma	11.99	33.28	35.42	6.46	0.26	2248	7715	11 897.43	54.21	2.03
Mesothelioma	6.05	10.54	4.75	−54.98	−4.07	1051	2289	1753.23	−23.41	−1.42
Myeloma	10.93	13.76	15.52	12.76	0.39	1729	3072	5228.66	70.20	2.35
Non-Hodgkin Lymphoma	23.02	32.45	31.56	−2.75	−0.23	4068	7440	10 489.40	40.99	1.54
Oesophagus	23.95	26.67	25.07	−6.00	−0.31	3911	6019	8365.78	38.99	1.57
Oral	13.27	21.38	28.40	32.84	1.10	2323	5124	8675.81	69.32	2.22
Pancreas	20.74	21.71	23.18	6.75	0.18	3321	4833	7874.14	62.92	2.19
Prostate	136.51	208.01	232.54	11.79	0.48	20 065	46 689	77 348.83	65.67	2.34
Stomach	42.75	19.80	15.27	−22.90	−1.24	6739	4353	5220.27	19.92	0.89
Testis	6.56	8.88	9.97	12.30	0.55	1639	2406	2920.80	21.40	0.91
Thyroid	1.59	3.91	6.93	77.43	2.49	310	964	2089.44	116.75	3.42
Other	70.47	47.87	49.78	3.98	0.22	11 204	10 659	16 527.69	55.06	2.11
All cancer sites	783.29	808.13	812.52	0.54	−0.03	126 682	182 091	270 260.90	48.42	1.82
Females
Cancer site
Anus	1.61	3.27	5.11	56.34	1.92	360	873	1748.81	100.32	3.09
Bladder	16.93	9.94	6.87	−30.95	−1.87	3881	2756	2855.27	3.60	0.11
Bone	0.69	0.86	1.06	24.16	0.85	169	235	351.39	49.53	1.77
Bowel	68.77	67.67	63.22	−6.58	−0.34	15 848	18 401	24 289.91	32.00	1.32
Brain	14.10	20.44	21.97	7.50	0.30	3233	5489	7397.15	34.76	1.35
Breast	160.46	204.93	209.51	2.24	0.14	35 585	54 833	71 022.04	29.52	1.26
Cervix	16.28	11.81	16.85	42.68	1.65	3805	3223	4792.35	48.69	1.86
Hodgkin lymphoma	2.17	3.21	3.17	−1.05	0.14	553	881	993.46	12.77	0.77
Kidney	8.51	17.27	20.42	18.21	0.70	1927	4634	7473.54	61.28	2.17
Larynx	2.12	1.48	1.45	−2.14	−0.43	469	389	498.93	28.26	0.81
Leukaemia	11.83	13.15	13.01	−1.10	−0.16	2753	3566	5043.55	41.43	1.52
Liver	3.02	6.87	8.32	21.02	0.52	692	1884	3363.86	78.55	2.38
Lung	62.61	80.94	80.46	−0.59	−0.12	14 177	21 633	29 957.38	38.48	1.44
Malignant melanoma	14.54	28.64	30.40	6.14	0.29	3374	7698	10 277.73	33.51	1.37
Mesothelioma	0.80	1.60	0.86	−45.98	−3.42	178	428	362.64	−15.27	−1.17
Myeloma	7.19	9.00	9.61	6.76	0.25	1644	2428	3659.35	50.71	1.90
Non-Hodgkin lymphoma	16.01	22.67	21.92	−3.32	−0.36	3651	6069	8131.89	33.99	1.21
Oesophagus	11.75	10.62	10.77	1.44	0.02	2730	2900	4291.51	47.98	1.81
Oral	5.52	9.61	12.71	32.24	1.15	1243	2556	4384.60	71.54	2.37
Ovary	27.22	27.67	31.89	15.23	0.61	6064	7367	10 500.59	42.54	1.58
Pancreas	15.47	17.60	18.38	4.47	0.12	3573	4783	7282.64	52.26	1.91
Stomach	17.66	8.48	7.72	−8.92	−0.47	4136	2329	3061.72	31.46	1.30
Thyroid	3.42	9.01	15.68	74.07	2.34	815	2424	4749.60	95.94	2.88
Uterus	21.84	35.51	33.09	−6.84	−0.39	4810	9323	11 576.13	24.17	0.95
Other	53.26	42.00	40.89	−2.62	−0.13	12 326	11 540	15 623.74	35.39	1.45
All cancer sites	563.75	664.27	685.37	3.18	0.11	127 996	178 642	243 689.80	36.41	1.43